Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.

"Declaration of personal interests: D.C and S.L received honoraria from Ferring and Pfizer outside of this work; N.C is funded by Crohn's and Colitis UK fellowship; NAK has consulted for Falk and received honoraria from Falk, Allergan, Pharmacosmos and Takeda for unrelated topics and is a deputy editor of Alimentary Pharmacology & Therapeutics Journal; JRG received honoraria from Falk, Abbvie and Shield therapeutics for unrelated topics; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; T.A has received unrestricted research grants, advisory board fees, speaker honorariums and support to attend international meetings from AbbVie, Merck, Janssen, Takeda, Ferring, Tillotts, Ferring, Pfizer, NAPP, Celltrion, Hospira for unrelated topics. C.G, B.H, NMH, P.H, E.W, IRD, N.S and M.O have no conflicts of interest to declare. Declaration of funding interests: None"

"Declaration of funding interests: None"